Daily news about corporate social responsibility, ethics and sustainability
Tags (5) : biopharmaceuticals
AsymBio Expands Biologics CDMO with New Shanghai R&D Center
07/27/2026 | Companies
AccPCC,
ADC,
AI-enabled platform,
analytical development,
antibodies,
antibody-drug conjugates,
AsymBio,
Asymchem Group,
biologics,
biologics development,
biologics manufacturing,
biopharmaceuticals,
biotech partnerships,
biotechnology,
CDMO,
cell line development,
chemistry manufacturing and controls,
clinical manufacturing,
CMC,
commercial manufacturing,
conjugation process,
contract development,
contract manufacturing,
downstream processing,
drug development,
drug product development,
Fengxian,
global biotech,
green building,
innovation,
life sciences,
low-carbon infrastructure,
manufacturing excellence,
PCC selection,
pharmaceutical manufacturing,
pharmaceutical research,
preclinical candidate,
process development,
R&D expansion,
R&D facility,
research and development,
scale-up manufacturing,
science to clinic,
Shanghai,
sustainable construction,
technology transfer,
translational research,
upstream processing
CordenPharma to Acquire AmbioPharm to Expand Peptide Manufacturing Platform
05/27/2026 | Companies
AmbioPharm,
API manufacturing,
Astorg,
biopharmaceuticals,
biotech industry,
BNP Paribas,
Carlyle Group,
CDMO,
China pharmaceutical manufacturing,
clinical peptide supply,
commercial peptide production,
contract development and manufacturing organization,
CordenPharma,
global peptide supply,
hybrid peptide synthesis,
LPPS,
North Augusta facility,
peptide API,
peptide APIs,
peptide commercialization,
peptide drug development,
peptide manufacturing,
peptide medicines,
peptide platform,
pharmaceutical acquisition,
pharmaceutical industry,
pharmaceutical manufacturing,
Shanghai manufacturing,
SPPS,
TAPS technology,
U.S. peptide manufacturing
Mabwell Advances 6MW5311 Bispecific Antibody for AML and Blood Cancers
04/16/2026 | Companies
6MW5311,
acute myeloid leukemia,
AML,
biopharmaceuticals,
biotechnology,
bispecific antibody,
cancer research,
CD3,
chronic myelomonocytic leukemia,
clinical trials,
CMML,
cytotoxicity,
drug development,
FDA,
hematologic malignancies,
immune synapse,
immunotherapy,
IND application,
LILRB4,
Mabwell,
MM,
multiple myeloma,
NMPA,
oncology,
preclinical studies,
stem cell transplantation,
steric hindrance,
T cell engager,
targeted therapy,
TCE technology,
tumor inhibition
Breakthrough HIV Treatment: Gilead's Innovative Drug Discovery Journey
04/03/2025 | Companies
antiviral therapy,
biopharmaceuticals,
biotechnology,
breakthrough medicine,
clinical trials,
drug discovery,
drug resistance,
Gilead,
global health,
healthcare innovation,
HIV,
HIV prevention,
HIV research,
HIV treatment,
medical innovation,
medical science,
pharmaceutical development,
Tomas Cihlar,
viral capsid,
virology
Gilead Sciences Leads in Innovation & Responsibility
03/20/2025 | Companies
biopharmaceuticals,
corporate responsibility,
drug development,
employee empowerment,
Foster City California,
Gilead Sciences,
global health,
global operations,
healthcare,
innovative medicines,
life-threatening illnesses,
medical innovation,
medical research,
responsible business,
top biopharma companies
Companies
Most Popular Now
Environment News
Compliance
Want to write a piece for Daily CSR? Please contact us by email at editor[@]dailycsr.com